Lv6
2180 积分 2020-12-07 加入
Advancements in locoregional therapy for advanced hepatocellular carcinoma: Emerging perspectives on combined treatment strategies
2天前
已完结
Interventional therapy for hepatocellular carcinoma in the immunotherapy era: From mechanism exploration to materials innovation
2天前
已完结
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients
3天前
已完结
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer
3天前
已完结
Global patterns of mutational profiles in biliary tract cancer
3天前
已完结
Current status and prospects of targeted therapy for cholangiocarcinoma based on molecular characteristics
4天前
已完结
Anatomical, histomorphological and molecular classification of cholangiocarcinoma
5天前
已完结
Genomic Pathway Alterations and Their Prognostic Impact in Biliary Tract Cancer: Insights from a Multinational Cohort Treated with Cisplatin, Gemcitabine, and Durvalumab
11天前
已完结
Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma
16天前
已完结
Adherence to Multidisciplinary Tumor Board Decisions Determines Long-term Survival in Patients with Hepatocellular Carcinoma
24天前
已完结
皖公网安备34019202002308
